• KR·Business+2
    Samsung Biologics Union Begins First General Strike
    Recent#1Active 3d2 updatesUpdated 1d ago
    What happened

    Samsung Biologics workers initiated a general strike, affecting production operations from May 1 to May 5.

    Why it matters

    As Samsung Biologics is a crucial player in the biopharmaceutical industry, the strike could lead to shortages in medical treatments worldwide, affecting international healthcare systems.

    Watch for

    Watch for statements from Samsung Biologics on the strike's impact, potential resolutions, and any response measures from health authorities or international partners.

    Decision context
    Samsung Biologics Management
    Decision on Strike Resolution Negotiation
    ImmediateIn Progress
    Decision on Strike Resolution Negotiation (by Samsung Biologics Management)
    In Progress
    Possible outcomes
    Prolonged Strike Causes Widespread Drug Shortages
    70%·Medium-term
    Successful Negotiation Ends Strike Early
    30%·Short-term
  • ZA·Science Biosecurity+1
    South Africa launches mass cattle vaccination amid foot-and-mouth outbreak
    Recent#2Active 2mo2 updatesUpdated 2d ago
    What happened

    A significant foot-and-mouth disease outbreak in South Africa has prompted a mass cattle vaccination program initiated by Agriculture Minister John Steenhuisen. The government has allocated emergency funds, and the most affected region, KwaZulu-Natal, is declared a national disaster area.

    Why it matters

    The outbreak poses a major threat to South Africa's livestock industry, with implications for export revenue, potential meat shortages, and job losses. Swift and effective containment measures are critical to mitigating economic and social impacts.

    Watch for

    Changes in meat import bans from affected countries, progress in vaccination coverage, and potential escalation or containment of the outbreak.

    Decision context
    FMD eradication strategy
    In Progress
    ActiveHigh Impact80High Risk70Low Signal19Cooling 4.4/dpriority jump +50.1Science BiosecurityTrade SupplyGeopolitical PressureBiosecurity & Public Health
  • GB·Business+2
    AstraZeneca announces £300 million UK investment
    Recent#3Active 4d1 updateUpdated 4d ago
    What happened

    AstraZeneca announced a significant investment of £300 million in the UK, focusing on two sites, reversing previous plans to halt large-scale projects.

    Why it matters

    This investment signifies a major boost to the UK's pharmaceutical sector, potentially leading to increased job creation, innovation, and enhanced pharmaceutical capabilities in the region, impacting global supply chains.

    Watch for

    Watch for detailed plans and timelines from AstraZeneca regarding the development of the two sites and any subsequent announcements from the UK government.

    Decision context
    UK Government
    Regulatory Approval of Investment Plans
    Short-termPending
    Possible outcomes
    Implementation Challenges
    30%·Medium-term
    Boost to UK pharmaceuticals
    70%·Medium-term
    ActiveMedium Impact40Medium Risk45Medium Signal57Cooling 15.9/d2 threshold jumpsBusinessScience BiosecurityTrade SupplyGeopolitical PressureBiosecurity & Public Health
  • TR·Science Biosecurity+1
    Ministry of Health reports critical cancer medication shortage
    Recent#4Active 4d1 updateUpdated 4d ago
    What happened

    A critical cancer medication shortage was reported by the Ministry of Health, impacting treatment plans for many patients.

    Why it matters

    This shortage could lead to disrupted treatment protocols and potentially worsen patient outcomes, highlighting vulnerabilities in the supply chain of essential medications.

    Watch for

    Watch for announcements from the Ministry of Health on new supply contracts or partnerships to resolve the medication shortage within the next 72 hours.

    Decision context
    Ministry of Health
    Address supply chain issues
    ImmediateIn Progress
    Possible outcomes
    Prolonged shortage impacts patient care
    35%·Short-term
    Medication shortage resolved
    65%·Short-term
    ActiveMedium Impact40Medium Risk60Low Signal37Cooling 15.0/d2 threshold jumpsScience BiosecurityTrade SupplyScience BiosecurityGeopolitical PressureBiosecurity & Public Health
offset 0 • limit 25